Manufacturers Life Insurance Company, The Gilead Sciences, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $100 Billion
- Q1 2025
A detailed history of Manufacturers Life Insurance Company, The transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 2,719,500 shares of GILD stock, worth $301 Million. This represents 0.3% of its overall portfolio holdings.
Number of Shares
2,719,500
Previous 6,308,718
56.89%
Holding current value
$301 Million
Previous $583 Million
47.71%
% of portfolio
0.3%
Previous 0.54%
Shares
35 transactions
Others Institutions Holding GILD
# of Institutions
2,289Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13.4 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$13 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.59 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.04 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.93 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $139B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...